Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Company release Nanoform Finland Plc November 19, 2024 20.45 Finnish…
Nanoform Finland Plc – Manager’s Transactions – Peter Hänninen
Company release Nanoform Finland Plc November 19, 2024 20.45 Finnish…
Nanoform Q3 2024 report: Record number of new projects signed
Nanoform Q3 2024 report: Record number of new projects signed…
Invitation to Nanoform’s Q3 2024 Report Presentation
Press release Nanoform Finland Plc November 4, 2024 11:00 a.m.…
Disclosure as attachment of the Nanoform 2022 Report of the Board of Directors and Financial Statements which were previously linked to a Company Release
Company release Nanoform Finland Plc October 25, 2024 16.15 Finnish…
Share subscriptions based on Nanoform Finland Plc’s stock options 2/2019
Company release Nanoform Finland Plc October 22, 2024 19.20 Finnish…
Nanoform and Celanese Expand Collaboration into Long-Acting Biologics Delivery Through Small Implants
Press release Nanoform Finland Plc September 5, 2024 08:10 a.m.…
Nanoform Q2 report: All business targets for 2024 on track
Company Announcement Nanoform Q2 report: All business targets for 2024…
Invitation to Nanoform’s Q2 2024 Report Presentation
Press release Nanoform Finland Plc August 16, 2024 11:00 a.m.…
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT
Press release Nanoform Finland Plc August 15, 2024 08:10 a.m.…
Nanoform Finland Plc – Manager’s Transactions – Miguel Calado
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Nanoform Finland Plc – Manager’s Transactions – Mads Laustsen
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Nanoform Finland Plc – Manager’s Transactions – Jeanne Thoma
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Share subscriptions based on the resolution by Nanoform Finland Plc’s Annual General Meeting 2024 on remuneration of the Board of Directors
Company release Nanoform Finland Plc June 14, 2024 17:00 Finnish…
Nanoform’s biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned
Company Announcement Nanoform Finland Plc May 30, 2024 08:10 a.m.…
Disclosure of Major Holdings under Law 163/2024
Company Release Nanoform Finland Plc May 29, 2024 12.30 Finnish…
Disclosure of Major Holdings under Law 163/2024
Company Release Nanoform Finland Plc May 29, 2024 12.30 Finnish…
Invitation to Nanoform’s Q1 2024 Report Presentation
Press release Nanoform Finland Plc May 16, 2024 11:00 a.m.…
Nanoformed High-Concentration Biologics Formulation for Subcutaneous Delivery Results to be Presented by Takeda at DDF Summit
Press Release Nanoform Finland Plc May 7, 2024 09.10 EEST…
Disclosure of Major Holdings under Law 163/2024
Company Release Nanoform Finland Plc April 26, 2024 11.00 Finnish…
New shares of Nanoform registered with the trade register
Company Release Nanoform Finland Plc April 25, 2024 17.00 Finnish…
Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines
Inside information Nanoform Finland Plc April 24, 2024 22.50 Finnish…
Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines
Inside information Nanoform Finland Plc April 24, 2024 18.31 Finnish…
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Company release Nanoform Finland Plc April 16, 2024 13.50 Finnish…
Resolutions of Nanoform Finland Plc’s Annual General Meeting on April 16, 2024
Company release Nanoform Finland Plc April 16, 2024 13.40 Finnish…
Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan
Press Release Nanoform Finland Plc April 11, 2024 09.00 EEST…
Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer
Press release Nanoform Finland Plc April 9, 2024 09.00 EEST…
Nanoform Finland Plc: Certified Adviser change to Carnegie Investment Bank Ab
Company release Nanoform Finland Plc April 8, 2024 09.00 Finnish…
The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals
Company release Nanoform Finland Plc March 26, 2024 19.30 Finnish…
Notice to the Annual General Meeting of NANOFORM FINLAND Plc
Notice to the Annual General Meeting of NANOFORM FINLAND Plc…
Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen
Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen Nanoform Finland Oyj:n (”Yhtiö”)…
Share subscriptions based on Nanoform Finland Plc’s stock options 2/2019 and 1/2020
Company release Nanoform Finland Plc March 12, 2024 18.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Miguel Calado
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Nanoform Finland Plc – Manager’s transactions – Albert Hæggström
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Nanoform Finland Plc – Manager’s transactions – Mads Laustsen
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Nanoform Finland Plc – Manager’s transactions – Jeanne Thoma
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Apalutamide Study Again Demonstrates the Advantages of Nanoforming Over Traditional Cancer Treatment Formulations
Press Release Nanoform Finland Plc February 29, 2024 08:11 a.m.…
Strong momentum in Project Nanoenzalutamide
Company Announcement Nanoform Finland Plc February 29, 2024 08:10 a.m.…
Invitation to Nanoform’s Q4 and FY 2023 Report Presentation
Press release Nanoform Finland Plc February 16, 2024 11:00 a.m.…
Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines
Inside information Nanoform Finland Plc February 15, 2024 12:45 Finnish…
Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide
Inside information Nanoform Finland Plc January 26th, 2024 11:20 Finnish…
Nanoform Finland Plc – Manager’s transactions – Albert Hæggström
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – David Rowe
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Edward Hæggström
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Peter Hänninen
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Christian Jones
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Johanna Kause
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Antonio Da Silva
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees
Company release Nanoform Finland Plc January 10, 2024 23:00 Finnish…
Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide
Press release Nanoform Finland Plc January 5, 2023 08:10 Finnish…